1,1,1,3,3,3-hexafluoropropan-2-yl 4-(4-(methylsulfonyl)-2-(pyrrolidin-1-yl)benzyl)piperazine-1-carboxylate

ID: ALA4436074

Chembl Id: CHEMBL4436074

PubChem CID: 155511585

Max Phase: Preclinical

Molecular Formula: C20H25F6N3O4S

Molecular Weight: 517.49

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1ccc(CN2CCN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2)c(N2CCCC2)c1

Standard InChI:  InChI=1S/C20H25F6N3O4S/c1-34(31,32)15-5-4-14(16(12-15)28-6-2-3-7-28)13-27-8-10-29(11-9-27)18(30)33-17(19(21,22)23)20(24,25)26/h4-5,12,17H,2-3,6-11,13H2,1H3

Standard InChI Key:  SPTBSRXDWQDJKA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4436074

    ---

Associated Targets(Human)

ABHD6 Tchem Monoacylglycerol lipase ABHD6 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGLL Tchem Monoglyceride lipase (1909 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G7 Tchem LDL-associated phospholipase A2 (1338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 517.49Molecular Weight (Monoisotopic): 517.1470AlogP: 3.44#Rotatable Bonds: 5
Polar Surface Area: 70.16Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.28CX LogP: 2.93CX LogD: 2.93
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.56Np Likeness Score: -1.30

References

1. Cisar JS, Weber OD, Clapper JR, Blankman JL, Henry CL, Simon GM, Alexander JP, Jones TK, Ezekowitz RAB, O'Neill GP, Grice CA..  (2018)  Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders.,  61  (20): [PMID:30067909] [10.1021/acs.jmedchem.8b00951]

Source